সুইজারল্যান্ড - জার্মান - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - sarilumabum - lösung zur injektion in fertigspritze - sarilumabum 200 mg, histidinum aut histidini hydrochloridum monohydricum, arginini hydrochloridum, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1.14 ml. - rheumatoide arthritis - biotechnologika

সুইজারল্যান্ড - জার্মান - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - sarilumabum - lösung zur injektion in einen stift ausgefüllt - sarilumabum 150 mg, histidinum aut histidini hydrochloridum monohydricum, arginini hydrochloridum, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1.14 ml. - rheumatoide arthritis - biotechnologika

সুইজারল্যান্ড - জার্মান - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - sarilumabum - lösung zur injektion in einen stift ausgefüllt - sarilumabum 200 mg, histidinum aut histidini hydrochloridum monohydricum, arginini hydrochloridum, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1.14 ml. - rheumatoide arthritis - biotechnologika

সুইজারল্যান্ড - জার্মান - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - guselkumabum - injektionslösung in einer fertigspritze - guselkumabum 100 mg, saccharum, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - plaque psoriasis, psoriasis-arthritis - biotechnologika

ইউরোপীয় ইউনিয়ন - জার্মান - EMA (European Medicines Agency)

almirall s.a - tildrakizumab - psoriasis - immunsuppressiva, interleukin-inhibitoren, - ilumetri ist indiziert für die behandlung von erwachsenen mit mittelschwerer bis schwerer plaque-psoriasis, die kandidaten für eine systemische therapie.

ইউরোপীয় ইউনিয়ন - জার্মান - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - immunsuppressiva - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.

সুইজারল্যান্ড - জার্মান - Swissmedic (Swiss Agency for Therapeutic Products)

almirall ag - tildrakizumabum - injektionslösung - tildrakizumabum 100 mg, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, saccharum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - plaque psoriasis bei erwachsenen - biotechnologika

সুইজারল্যান্ড - জার্মান - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - tocilizumabum - injektionslösung in einem fertigpen zur subkutanen anwendung - tocilizumabum 162 mg, polysorbatum 80, arginini hydrochloridum, methioninum, histidinum, histidini hydrochloridum monohydricum, aqua ad iniectabile q.s. ad solutionem pro 0.9 ml. - rheumatoide arthritis, riesenzellarteriitis, polyartikuläre juvenile idiopathische arthritis, systemische juvenile idiopathische arthritis - biotechnologika

সুইজারল্যান্ড - জার্মান - Swissmedic (Swiss Agency for Therapeutic Products)

abbvie ag - risankizumabum - lnjektionslösung in einer fertigspritze - lösung: risankizumabum 75.0 mg, sorbitolum 34 mg, dinatrii succinas hexahydricus corresp. natrium 0.149 mg, natrium 0.149 mg, acidum succinicum, polysorbatum 20, aqua ad iniectabile ad solutionem pro 0.83 ml. tela cum: alcohol isopropylicus. - plaque-psoriasis bei erwachsenen, psoriasis-arthritis - biotechnologika

সুইজারল্যান্ড - জার্মান - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - guselkumabum - injektionslösung im fertigpen - guselkumabum 100 mg, saccharum, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - plaque psoriasis, psoriasis-arthritis - biotechnologika